Korean Drug Co., Ltd. (KOSDAQ:014570)
South Korea
· Delayed Price · Currency is KRW 4,885.00
0.00 (0.00%)
At close: May 13, 2025, 3:30 PM KST
Korean Drug Revenue
In the year 2024, Korean Drug had annual revenue of 73.00B KRW, down -10.29%. Korean Drug had revenue of 17.70B in the quarter ending December 31, 2024, a decrease of -7.37%.
Revenue
73.00B
Revenue Growth
-10.29%
P/S Ratio
0.73
Revenue / Employee
270.38M
Employees
270
Market Cap
53.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 73.00B | -8.37B | -10.29% |
| Dec 31, 2023 | 81.37B | 1.39B | 1.74% |
| Dec 31, 2022 | 79.98B | 5.52B | 7.41% |
| Dec 31, 2021 | 74.47B | 7.68B | 11.49% |
| Dec 31, 2020 | 66.79B | 11.26B | 20.28% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.07T |
| SK hynix | 71.40T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 11.24T |
| Kia Corporation | 107.45T |
| HD Hyundai Heavy Industries | 14.49T |